Buruli ulcer

The candidate tuberculosis vaccine Mtb72F/AS02A: Tolerability and immunogenicity in humans

(2014) Kenneth Von Eschen et al.   Human vaccines & immunotherapeutics

Chemistry of mycolactones, the causative toxins of Buruli ulcer

(2011) Y. Kishi   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Ag85B–ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection

(2011) Jaap T. van Dissel et al.   VACCINE

Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: Second report of the BCG-REVAC cluster-randomised trial

(2011) Mauricio L. Barreto et al.   VACCINE

BCG-Mediated Protection against Mycobacterium ulcerans Infection in the Mouse

(2011) Paul J. Converse et al.   PLoS Neglected Tropical Diseases

Activities of Rifampin, Rifapentine and Clarithromycin Alone and in Combination against Mycobacterium ulcerans Disease in Mice

(2011) Deepak Almeida et al.   PLoS Neglected Tropical Diseases

Oral Treatment for Mycobacterium ulcerans Infection: Results From a Pilot Study in Benin

(2010) Annick Chauty et al.   CLINICAL INFECTIOUS DISEASES

Buruli Ulcer: Advances in Understanding Mycobacterium ulcerans Infection

(2010) Douglas S. Walsh et al.   DERMATOLOGIC CLINICS

Application of real-time PCR in Ghana, a Buruli ulcer-endemic country, confirms the presence ofMycobacterium ulceransin the environment

(2010) Koen Vandelannoote et al.   FEMS MICROBIOLOGY LETTERS

MycobacteriumulceransTriggers T-Cell Immunity followed by Local and Regional but Not Systemic Immunosuppression

(2010) Alexandra G. Fraga et al.   INFECTION AND IMMUNITY

Fighting mycobacterial infections by antibiotics, phytochemicals and vaccines

(2010) Denise Bamberger et al.   MICROBES AND INFECTION

Serological Evaluation of Mycobacterium ulcerans Antigens Identified by Comparative Genomics

(2010) Sacha J. Pidot et al.   PLoS Neglected Tropical Diseases

A Major Role for Mammals in the Ecology of Mycobacterium ulcerans

(2010) Janet A. M. Fyfe et al.   PLoS Neglected Tropical Diseases

Ecology and Transmission of Buruli Ulcer Disease: A Systematic Review

(2010) Richard W. Merritt et al.   PLoS Neglected Tropical Diseases

Cross-Reactive Immunity to Mycobacterium tuberculosis DosR Regulon-Encoded Antigens in Individuals Infected with Environmental, Nontuberculous Mycobacteria

(2009) M. Y. Lin et al.   INFECTION AND IMMUNITY

Mycolactone Suppresses T Cell Responsiveness by Altering Both Early Signaling and Posttranslational Events

(2009) S. Boulkroun et al.   JOURNAL OF IMMUNOLOGY

Mycolactone Inhibits Monocyte Cytokine Production by a Posttranscriptional Mechanism

(2009) R. E. Simmonds et al.   JOURNAL OF IMMUNOLOGY

Immunosuppressive Signature of CutaneousMycobacterium ulceransInfection in the Peripheral Blood of Patients with Buruli Ulcer Disease

(2009) Richard Phillips et al.   JOURNAL OF INFECTIOUS DISEASES

Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer

(2009) Manuel T Silva et al.   LANCET INFECTIOUS DISEASES

Buruli ulcer disease: prospects for a vaccine

(2009) Kris Huygen et al.   MEDICAL MICROBIOLOGY AND IMMUNOLOGY

Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime–boost regimen

(2009) Yasir A.W. Skeiky et al.   VACCINE

Persistent Association of Mycobacterium ulcerans with West African Predaceous Insects of the Family Belostomatidae

(2008) L. Mosi et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Independent Loss of Immunogenic Proteins in Mycobacterium ulcerans Suggests Immune Evasion

(2008) C. A. Huber et al.   Clinical and Vaccine Immunology

Humoral Response AgainstMycobacterium bovisHsp65 Derived Fragments in Children and Young People with Various Disorders

(2008) Thi Thu Hien Nguyen et al.   JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY

Mycolactones: immunosuppressive and cytotoxic polyketides produced by aquatic mycobacteria

(2008) Hui Hong et al.   NATURAL PRODUCT REPORTS

rBCG Induces Strong Antigen-Specific T Cell Responses in Rhesus Macaques in a Prime-Boost Setting with an Adenovirus 35 Tuberculosis Vaccine Vector

(2008) Isabelle Magalhaes et al.   PLoS One

Improved Protective Efficacy of a Species-Specific DNA Vaccine Encoding Mycolyl-Transferase Ag85A from Mycobacterium ulcerans by Homologous Protein Boosting

(2008) Audrey Tanghe et al.   PLoS Neglected Tropical Diseases